1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Amedisys, Inc.

Amedisys, Inc.

AMED
Amedisys, Inc.US flagNASDAQ Global Select
100.99
USD
+0.01
- -
3.32BMarket Cap
Amedisys, Inc.
AMED
(NASDAQ Global Select)

Recent

price

100.99

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
55.58
57.12
49.44
48.19
39.98
37.29
38.78
42.75
44.84
50.7
60.84
63.62
67.83
68.37
68.6
71.77
73.28
Revenue per Share
4.99
4.02
-13.33
-2.8
-3.08
0.4
-0.09
1.12
0.9
3.64
3.95
5.64
6.4
3.65
-0.3
1.32
2.61
Basic EPS, GAAP
7.57
4.99
3.37
0.71
1.94
-2.4
2.62
1.4
2.82
6.62
6.04
8.71
5.58
3.88
3.82
6.55
7.14
Free Cash Flow per Basic Share
- -
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
13.67
17.29
3.56
0.62
-2.48
-2
-2.05
-0.92
0.01
3.65
7.67
13.21
19.58
23.3
22.94
24.18
26.85
Book Value per Share
-3.97
1.25
4.72
6.61
4.06
4.92
3.17
3.78
4.46
3.32
-2.54
-6.02
-10.14
-8.67
-6.98
-3.52
-0.56
Tangible Book Value per Share
27
28
29
30
31
32
33
33
34
33
32
33
33
33
33
33
33
Basic Weighted Avg Shares
1,513
1,601
1,418
1,441
1,249
1,205
1,281
1,419
1,511
1,663
1,956
2,072
2,214
2,223
2,236
2,348
2,402
Sales/Revenue/Turnover
15.25
13.2
7.81
3.7
0.36
2.25
5.32
4.35
7.18
9.33
9.15
10.79
11.38
8.27
8.63
8.92
9.41
Operating Margin (%)
28
35
40
40
37
28
20
20
17
13
54
68
71
71
58
60
62
Depreciation Expense
136
113
-382
-84
-96
13
-3
37
30
119
127
184
209
119
-10
43
86
Net Income, GAAP
38.75
38.97
- -
- -
- -
36.57
- -
38.88
62.03
24.44
24.94
12.16
25
26.55
127.6
55.74
45.16
Effective Tax Rate (%)
8.98
7.03
-26.96
-5.8
-7.7
1.06
-0.24
2.63
2
7.18
6.49
8.86
9.44
5.34
-0.44
1.84
3.56
Profit Margin (%)
-11
78
10
1
-107
-27
- -
34
96
2
24
-94
-18
33
23
118
174
Working Capital
171
145
112
67
33
104
92
88
78
6
288
266
501
489
425
395
387
LT Debt
736
880
520
454
372
398
410
461
516
483
642
811
976
1,107
1,120
1,180
1,275
Total Equity
15.21
12.65
- -
- -
- -
3.77
- -
7.34
7.35
21.74
18.35
18.76
14.28
8.52
-3.28
5.71
7.34
Return on Invested Capital (%)
24.71
18.7
- -
- -
- -
144.46
- -
85.04
41.09
113.31
38.96
29.22
21.86
10.53
-1.3
4.79
7.75
Return on Capital (%)
44.65
26.28
-130.33
-138.29
- -
- -
- -
- -
- -
199.2
69.31
54.29
39.11
16.98
-1.29
5.62
10.22
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
64
63
64
LT Borrowings
339
333
326
LT Finance Leases
56
56
60
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
33
33
33
Market Capitalization
2,970
3,034
3,226

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
632
634
662
Cash, Cash Equivalents & STI
303
285
337
Accounts Receivable, Net
296
320
296
Inventories
- -
- -
- -
Total Current Liabilities
514
492
488
Payables & Accruals
303
323
319
ST Debt
64
63
64
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.06%
13.34%
5.37%
Free Cash Flow
1.49%
10.09%
72.16%
Net Income, GAAP
-181.2%
-127.28%
-543.53%
Sales/Revenue/Turnover
7.01%
3.76%
5.01%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
556
553
556
571
2,236
2024
571
591
588
598
2,348
2025
595
622
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.78
-2.46
0.8
0.59
-0.3
2024
0.44
0.99
0.52
-0.62
1.32
2025
1.86
0.85
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Life Healthcare Group Holdings Limited (LTGHF)
Chiang Mai Ram Medical Business Public Company Limited (CMR.BK)
Medicover AB (publ) (MCVEY)
Centrum Medyczne ENEL-MED S.A. (ENE.WA)
MD Medical Group Investments Plc (MDMG.ME)
EuKedos S.p.A. (EUK.MI)
Business
Amedisys, Inc. (AMED) operates as a leading provider of home-based healthcare services in the United States, delivering home health, hospice, palliative, and high-acuity care to patients nationwide. Founded in 1982 and headquartered in Baton Rouge, Louisiana, with an additional executive office in Nashville, Tennessee, the company offers skilled nursing; physical, occupational, and speech therapy; medical social work; home health aides; personal care services including companion care, homemaker services, and live-in care; hospice care encompassing pain and symptom management, emotional and spiritual support, and bereavement counseling; palliative care for symptom relief and quality-of-life enhancement; and high-acuity care through its Contessa Health division featuring IV therapy, wound care, remote patient monitoring, and telehealth for hospital-level needs at home. Amedisys serves patients recovering from illness or surgery, those with chronic conditions, and individuals with life-limiting illnesses, primarily through Medicare reimbursement, across a network of care centers that supports over 499,000 patients annually with approximately 19,000 employees. As of August 14, 2025, Amedisys functions as a subsidiary of Optum, Inc., following Optum's $3.3 billion acquisition completed after regulatory settlement requiring divestiture of 164 locations; certain divested home health and hospice assets, generating $187 million in revenue from 54 locations, were acquired by Pennant Group in late 2025, while others went to BrightSpring, marking a major restructuring to facilitate the UnitedHealth Group integration.

Company News

APIChat

  • gurufocus.com

    Joel Greenblatt's Strategic Moves: A Closer Look at SPDR S&P 500 ETF Trust

  • prnewswire.com

    Twilio Set to Join S&P MidCap 400

  • seekingalpha.com

    Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors

  • zacks.com

    Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?

  • fool.com

    Amedisys (AMED) Q2 Revenue Tops 5%

  • zacks.com

    Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings

  • zacks.com

    Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates

  • globenewswire.com

    Amedisys Reports Second Quarter 2025 Financial Results

  • zacks.com

    Here's Why You Should Retain AMED Stock in Your Portfolio for Now

  • zacks.com

    AMED or CHE: Which Is the Better Value Stock Right Now?

  • zacks.com

    Are Medical Stocks Lagging Amedisys (AMED) This Year?

  • zacks.com

    AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise

  • zacks.com

    Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics

  • zacks.com

    Amedisys (AMED) Tops Q1 Earnings Estimates

  • globenewswire.com

    Amedisys Reports First Quarter 2025 Financial Results

  • zacks.com

    Amedisys (AMED) Earnings Expected to Grow: Should You Buy?

  • zacks.com

    Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?

  • zacks.com

    Here's Why You Should Retain AMED Stock in Your Portfolio Now

  • zacks.com

    AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises

  • zacks.com

    Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say